Saint Louis University is a private Jesuit research university with campuses in St. Louis, Missouri, United States, and Madrid, Spain. Founded in 1818 by Louis William Valentine DuBourg, it is the oldest university west of the Mississippi River and the second-oldest Jesuit university in the United States.

During the past decade, Saint Louis University conducted 165 clinical trials. In the 10-year time frame, 165 clinical trials started and 106 clinical trials were completed, i.e. on average, 64.2% percent of trials that started reached the finish line to date. In the past 5 years, 70 clinical trials started and 62 clinical trials were completed. i.e. 88.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Louis University" #1 sponsor was "St. Louis University" with 45 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 20 trials sponsored, "Gilead Sciences" with 15 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 14 trials sponsored and "Bristol-Myers Squibb" with 14 trials sponsored. Other sponsors include 245 different institutions and companies that sponsored additional 186 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Louis University" #1 collaborator was "St. Louis University" with 12 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 9 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 5 trials as a collaborator and "University of Pittsburgh" with 5 trials as a collaborator. Other collaborators include 261 different institutions and companies that were collaborators in the rest 190 trials.

According to Clinical.Site data, the most researched conditions in "Saint Louis University" are "Influenza" (14 trials), "Hepatitis C" (13 trials), "Nonalcoholic Steatohepatitis" (9 trials), "Cystic Fibrosis" (7 trials) and "Hepatitis C, Chronic" (7 trials). Many other conditions were trialed in "Saint Louis University" in a lesser frequency.

Most popular intervention types in "Saint Louis University" are "Drug" (204 trials), "Biological" (48 trials), "Device" (41 trials), "Other" (38 trials) and "Procedure" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (78 trials), "Ribavirin" (10 trials), "placebo" (5 trials), "Telaprevir" (4 trials) and "BMS-986036" (3 trials). Other intervention names were less common.

The vast majority of trials in "Saint Louis University" are 323 trials for "All" genders, 18 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Louis University". 2 are not yet recruiting, 38 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 224 completed trials in Saint Louis University, 1 suspended trials, and 52 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Louis University, 26 "Phase 1" clinical trials were conducted, 92 "Phase 2" clinical trials and 120 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 56 trials that are defined as “Not Applicable".

Saint Louis University has several departments that took part in Clinical trials: "Saint Louis University - Center for Vaccine Development" - 46 trials, "Saint Louis University Dermatology" - 23 trials, "St. Louis University Ophthalmology" - 6 trials, "Saint Louis University, Gastroenterology & Hepatology" - 6 trials, "Saint Louis University - Doisy Research Center" - 4 trials, "Saint Louis University Center for Advanced Dental Education" - 3 trials, "Saint Louis University Department of Neurology" - 3 trials, "Department of Neurology and Psichiatry, Saint Louis University" - 2 trials, "Saint Louis University Hospital - Internal Medicine - Infectious Diseases, Allergy & Immunology" - 2 trials